tirzepatide approved for sleep apnea The FDA has just Zepbound (tirzepatide), the first medication designed to treat both obstructive apnoea (OSA) and obesity simultaneously. In clinical trials, Zepbound helped reduce breathing disruptions by 50% and Ozempic and sleep apnea: What

Benefits emerge within weeks through improved blood sugar stability, reduced appetite dysregulation, and enhanced metabolic flexibilitymeasurable improvements beyond the scale

Many patients report meaningful reductions in widespread pain as they lose weight, consistent with reduced mechanical load and lower systemic inflammation

The Pill Problem: Oral GLP-1s can affect the absorption of other medications, including oral contraceptives, requiring careful consideration and potential adjustments in dosing schedules

During a recent clinical trial, Wegovy lowered the risk of MACE by 20% compared to placebo (an injection without medication in it)

Drink 8oz each time

IBS Nutritionist Hi, Im Anna Mapson, registered Nutritional Therapist